Tristel Plc (TSTL) Rating Reiterated by FinnCap
Tristel Plc (LON:TSTL)‘s stock had its “corporate” rating reissued by analysts at FinnCap in a research note issued on Tuesday. They currently have a GBX 150 ($1.86) price objective on the stock. FinnCap’s price objective would suggest a potential downside of 12.79% from the stock’s previous close.
Shares of Tristel Plc (LON:TSTL) opened at 172.00 on Tuesday. The company’s market capitalization is GBX 72.52 million. Tristel Plc has a 12 month low of GBX 87.11 and a 12 month high of GBX 176.00. The firm’s 50-day moving average is GBX 158.49 and its 200 day moving average is GBX 133.59.
The firm also recently declared a dividend, which will be paid on Friday, December 16th. Stockholders of record on Thursday, November 17th will be given a dividend of GBX 2.19 ($0.03) per share. This represents a dividend yield of 1.41%. The ex-dividend date is Thursday, November 17th.
About Tristel Plc
Tristel plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used for infection control in hospitals.
Receive News & Stock Ratings for Tristel Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel Plc and related stocks with our FREE daily email newsletter.